Lmcg Investments LLC Has $4.81 Million Stock Position in Stryker Corporation $SYK

Lmcg Investments LLC raised its position in Stryker Corporation (NYSE:SYK) by 84.2% in the first quarter, HoldingsChannel reports. The fund owned 14,644 shares of the medical technology company’s stock after purchasing an additional 6,694 shares during the quarter. Lmcg Investments LLC’s holdings in Stryker were worth $4,812,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of SYK. Godfrey Financial Associates Inc. acquired a new position in shares of Stryker during the fourth quarter worth approximately $26,000. Sankala Group LLC bought a new stake in Stryker during the 4th quarter valued at $26,000. United Financial Planning Group LLC bought a new stake in Stryker during the 3rd quarter valued at $27,000. Atlas Capital Advisors Inc. acquired a new position in Stryker during the fourth quarter worth $27,000. Finally, DJE Kapital AG acquired a new position in Stryker during the fourth quarter worth $28,000. Institutional investors own 77.09% of the company’s stock.

Insider Activity

In other news, VP Robert S. Fletcher sold 4,544 shares of the firm’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the completion of the sale, the vice president directly owned 10,582 shares of the company’s stock, valued at $3,247,298.34. This trade represents a 30.04% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP M Kathryn Fink sold 3,500 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $283.45, for a total transaction of $992,075.00. Following the completion of the transaction, the vice president directly owned 177 shares in the company, valued at $50,170.65. This trade represents a 95.19% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 323,264 shares of company stock valued at $100,659,489 in the last ninety days. 4.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

SYK has been the subject of a number of analyst reports. Weiss Ratings cut shares of Stryker from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, May 4th. BMO Capital Markets initiated coverage on shares of Stryker in a research report on Wednesday. They issued an “outperform” rating and a $369.00 price target on the stock. Sanford C. Bernstein set a $410.00 price target on Stryker in a research note on Friday, May 1st. Canaccord Genuity Group decreased their price objective on Stryker from $435.00 to $400.00 and set a “buy” rating for the company in a report on Friday, May 1st. Finally, Barclays dropped their target price on Stryker from $469.00 to $394.00 and set an “overweight” rating on the stock in a report on Monday, May 4th. Seventeen analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $393.91.

Stryker Trading Down 0.8%

Shares of SYK stock opened at $327.17 on Thursday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11. The company has a market capitalization of $125.42 billion, a price-to-earnings ratio of 37.87, a PEG ratio of 2.11 and a beta of 0.77. Stryker Corporation has a 52-week low of $281.00 and a 52-week high of $404.87. The company has a 50-day simple moving average of $309.71 and a two-hundred day simple moving average of $338.22.

Stryker (NYSE:SYK) last announced its earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The business had revenue of $6.02 billion during the quarter, compared to analysts’ expectations of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.Stryker’s quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.84 EPS. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Research analysts anticipate that Stryker Corporation will post 14.98 EPS for the current fiscal year.

Stryker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be paid a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date is Tuesday, June 30th. Stryker’s dividend payout ratio is 40.74%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.